Pharma Consulting Group AB Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Uppsala Sweden (2003)
Status: Acquired by LINK Medical (2018)

Organization Overview

First Clinical Trial
2009
NCT00808509
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pharma Consulting Group | Pharma Consulting Group (PCG)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atrophy (Phase 2)

Cerebral Infarction (Phase 2)

Cognitive Dysfunction (Phase 2)

Colorectal Neoplasms (Phase 2)

Ischemia (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8